PMC6352632_01
Pelvic ultrasound showing a big uterine mass with inhomogeneous echogenicity
IJNM-34-60-g001.jpg
PMC6352632_01_IJNM-34-60-g001.jpg
F1
Ultrasounds examinations revealed a big solid mass in the cervix with an inhomogeneous echogenicity and no evidence of significant ovarian alterations [Figure 1].
Positron emission tomography/computerized tomography sagittal scan showing a big hypermetabolic uterine mass (yellow arrow) with maximum standardized uptake value 16.2 g/ml bw
IJNM-34-60-g002.jpg
PMC6352632_01_IJNM-34-60-g002.jpg
F2
The images showed an uterine mass extended from fundus to cervix (longitudinal diameter 58 mm and axial diameter 64 mm), with a high uptake of 18[F] FDG (maximum standardized uptake value [SUVmax]) 16.2 g/ml bw, metabolic volume tumor 17 cm3) [Figure 2].
Axial and sagittal computerized tomography scan showing contrast enhancement in the uterine mass
IJNM-34-60-g003.jpg
PMC6352632_01_IJNM-34-60-g003.jpg
F3
The mass also showed contrast enhancement after iodinate contrast administration [Figure 3].
Positron emission tomography, computerized tomography with iodinated contrast and positron emission tomography/computerized tomography axial scans showing the involvement of the right ovary (orange arrows)
IJNM-34-60-g004.jpg
PMC6352632_01_IJNM-34-60-g004.jpg
F4
Moreover, the right ovary presented a moderate enlargement (40 mm x 23 mm) and a big uptake of the radiopharmaceutical (SUVmax 7.7 g/ml bw) [Figure 4].